Company news

IXICO PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Trading Update for year ended 30 September 2019

October 15, 2019

IXICO provides update on new & current contracts

August 9, 2019

Director and PDMR share purchase

July 11, 2019

Half Yearly Report to 31 March 2019

May 22, 2019

Update for first half of year ending 31 March 2019

April 25, 2019

Announces two new biopharmaceutical contracts

April 24, 2019

Change of Adviser

April 12, 2019

Late phase clinical study in Huntington's disease

March 5, 2019

IXICO chosen for new Medical Imaging & AI Centre

March 1, 2019

Appointment of Chief Financial Officer

February 7, 2019

Final Results

December 4, 2018

Pre-Close Trading Update

October 15, 2018

Result of General Meeting - Amended

September 21, 2018

Contract with top 10 global pharmaceutical company

September 11, 2018

Proposed Capital Reorganisation

September 3, 2018

Contract expansion with biopharmaceutical company

August 30, 2018

Trading Statement

August 21, 2018

Agreement

August 13, 2018

Implementation of Long Term Incentive Plan

June 13, 2018

Notification of the cessation of a clinical trial

June 12, 2018

Result of General Meeting

May 29, 2018

New contract with top 10 pharmaceutical company

May 14, 2018

Expansion of two biopharmaceutical contracts

May 10, 2018

Notice of Interim Results

May 3, 2018

New contract in progressive supranuclear palsy

January 30, 2018

AGM Statement and Board Changes

January 22, 2018

Strategic and Operational Update

November 28, 2017

Contract to Deploy Biosensors in Clinical Trial

November 16, 2017

New contract to support Phase II clinical trial

October 4, 2017

New contract in Huntington's disease

September 28, 2017

New Contract with Biopharmaceutical Company

September 25, 2017

Extension of a 5 year contract

September 5, 2017

Expansion of Collaboration with Biogen

July 24, 2017

IXICO hosts Alzheimer Expert Symposium

July 18, 2017

New contract for imaging clinical trial services

July 5, 2017

Half Yearly Report to 31 March 2017

May 22, 2017

Notice of H1 Results

May 16, 2017

Exercise of share options

April 12, 2017

Exercise of Share Options

March 29, 2017

IXICO signs US$1.5m contract

March 13, 2017

To present novel sleep measurement technology

March 10, 2017

Appointment of Giulio Cerroni as CEO

January 17, 2017

Annual Report and Accounts and Notice of AGM

January 16, 2017

Issue of 590,093 Deferred Consideration Shares

January 4, 2017

Buyback and Cancellation of Deferred Shares

December 23, 2016

Full Year Results

December 20, 2016

Participation in major EU partnership (ROADMAP)

November 16, 2016

$1.2m contract with new global pharma customer

October 20, 2016

IXICO presents at CAMD regulatory workshop

October 19, 2016

EUR1m funding as a partner in major EU consortium

October 10, 2016

← Newer news releases · Older news releases →

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.